Welcome to the Office of Research and Development
The Office of Research and Development houses the University's research administration, corporate contract and technology commercialization efforts and leads global and economic development initiatives including the University of Maryland BioPark and Global Health Initiatives. Our staff is available to assist you.
Please visit our web portal for more information: Research @ UM
James L. Hughes
News and Announcements
School of Pharmacy with UM Ventures hosted entrepreneurial lecture on November 19th.
Read the SOP News article
International businessman, entrepreneur, and UM School of Pharmacy alumnus Dr. John M. Gregory was one of the very first entrepreneurial success stories on the UMB campus.
The Global Health Interprofessional Council hosted a roundtable conference on "Building Global Health Team Excellence" on October 25th. Forty two invited experts in interprofessional education (IPE) and global health education worked together in six small groups for a day determining what IPE concepts (e.g., communication, shared values, team work) should be part of a well-designed global health education program. View photos from the conference
Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases - Gliknik press release (9/30/13)
NIH Renews Funding for UM Vaccine Research in Response to Emerging Public Health Issues - Read the UMB News article (9/27/13)
MedImmune and University of Maryland, Baltimore Announce Five-year, $6 Million Research Collaboration to Drive Science Innovation in Maryland
Collaboration to drive novel bioscience research - MedImmune Press Release (9/25/13)
UMB, MedImmune form partnership to advance biomedical science and innovation - Read the UMB News article (9/25/13)
UM's 2013 Entrepreneur of the Year, Dr. Magaly Rodriguez de Bittner - read more
UM's 2013 Researcher of the Year, Dr. W. Jonathan Lederer - read more
UMB's Partnership with Rexahn Pharmaceuticals - Exclusive license to Rexahn for development of cancer drug delivery platform co-developed by researchers at UMB's School of Pharmacy (7/17/13) - Press Release (PDF): Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform: Maximizes efficacy and minimizes toxicity of currently marketed anti-cancer drugs RX-21101 identified as first development candidate from platform
Maryland Industrial Partnerships funds UMB Investigators - UMD Program Awards $3.8 Million to 17 University, Maryland Company Teams to Develop Technology Products - Wall Street Journal (7/16/13) - University of Maryland tech program awards $3.8M to researchers - Baltimore Business Journal (7/16/13)
University of Maryland Establishes Center for Health-Related Informatics and Bioimaging - Read the SOM News Article (6/10/13)
2013 USM Entrepreneur of the Year - Scott Strome - Watch the video!
USM Board of Regents Honors 3 Winners of Inaugural Entrepreneur of the Year Award: Winners' Entrepreneurial Success Reflected in Support of UM Ventures - Read the USM News Article (5/14/13)
Comparative Effectiveness Research seminar series and other resources